NO20076360L - Dengue serotype 2 attenuert stamme - Google Patents

Dengue serotype 2 attenuert stamme

Info

Publication number: NO20076360L
Authority: NO; Norway
Prior art keywords: dengue serotype; attenuated strain; strain; vdv2; dengue
Prior art date: 2005-06-17

Application number

NO20076360A

Other languages

English (en)

Norwegian (no)

Inventor

Richard Kinney

Claire Huang

Veronique Barban

Jean Lang

Bruno Guy

Original Assignee

Ct S For Disease Control And P

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-17

Filing date

2007-12-12

Publication date

2008-03-11

2007-12-12 Application filed by Ct S For Disease Control And P filed Critical Ct S For Disease Control And P

2008-03-11 Publication of NO20076360L publication Critical patent/NO20076360L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/08—Inactivation or attenuation by serial passage of virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
- C12N2770/24164—Methods of inactivation or attenuation by serial passage
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

NO20076360A 2005-06-17 2007-12-12 Dengue serotype 2 attenuert stamme NO20076360L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US69127405P	2005-06-17	2005-06-17
PCT/IB2006/001513 WO2006134443A1 (en)	2005-06-17	2006-06-07	Dengue serotype 2 attenuated strain

Publications (1)

Publication Number	Publication Date
NO20076360L true NO20076360L (no)	2008-03-11

Family

ID=37103341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20076360A NO20076360L (no)	2005-06-17	2007-12-12	Dengue serotype 2 attenuert stamme

Country Status (18)

Country	Link
US (4)	US7641908B2 (de)
EP (1)	EP1891210B1 (de)
JP (1)	JP5075120B2 (de)
KR (2)	KR20080018271A (de)
CN (1)	CN101238209B (de)
AR (1)	AR053914A1 (de)
AT (1)	ATE475706T1 (de)
AU (1)	AU2006257621B2 (de)
BR (1)	BRPI0613287A2 (de)
CA (1)	CA2611954C (de)
DE (1)	DE602006015807D1 (de)
IL (1)	IL188068A0 (de)
MX (1)	MX2007015872A (de)
MY (2)	MY144542A (de)
NO (1)	NO20076360L (de)
TW (1)	TWI375722B (de)
WO (1)	WO2006134443A1 (de)
ZA (1)	ZA200710752B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5075120B2 (ja) *	2005-06-17	2012-11-14	サノフィ・パスツール	デング熱セロタイプ２の弱毒化株
CU23586A1 (es) *	2005-11-22	2010-10-30	Ct Ingenieria Genetica Biotech	Métodos y proteínas para el tratamiento profiláctico y/o terapéutico de los cuatro serotipos del virus de dengue y otros flavivirus
FR2903605A1 (fr) *	2006-07-12	2008-01-18	Sanofi Pasteur Sa	Methode d'immunisation contre les quatres serotypes de la dengue
FR2909286B1 (fr) *	2006-12-01	2012-06-08	Sanofi Pasteur	Methode d'immunisation contre les 4 serotypes de la dengue
CN101139638B (zh) *	2007-05-08	2010-05-26	深圳太太基因工程有限公司	一种用于检测登革病毒ⅲ型核苷酸片段的引物和探针序列
CN105944095B (zh)	2008-03-05	2021-04-02	赛诺菲巴斯德有限公司	一种使含佐剂的疫苗组合物稳定的方法
EP2143440A1 (de)	2008-07-09	2010-01-13	Sanofi Pasteur	Stabilisierungssubstanz und Impfzusammensetzung, die ein oder mehrere abgeschwächte lebende Flaviviridae enthält
US8968996B2 (en) *	2009-06-01	2015-03-03	Takeda Vaccines, Inc.	Compositions and methods for rapid immunization against dengue virus
JP5848243B2 (ja)	2009-06-01	2016-01-27	タケダワクチン, インコーポレイテッドTakeda Vaccines, Inc.	デングウイルスに対する免疫原性組成物
WO2011026139A1 (en)	2009-08-31	2011-03-03	Gen-Probe Incorporated	Dengue virus assay
CN102755642B (zh) *	2012-07-13	2014-01-08	中国食品药品检定研究院	一种炭疽疫苗的制备方法
MY197723A (en)	2012-07-24	2023-07-10	Sanofi Pasteur	Vaccine compositions for the prevention of dengue virus infection
BR112015001313A2 (pt) *	2012-07-24	2017-08-01	Sanofi Pasteur	composições de vacina
WO2014083194A1 (en)	2012-11-30	2014-06-05	Sanofi Pasteur	Methods for inducing antibodies
WO2014093182A1 (en)	2012-12-14	2014-06-19	Inviragen, Inc.	Compositions, methods of administration and uses for trivalent dengue virus formulations
PE20211814A1 (es) *	2013-03-15	2021-09-14	Takeda Vaccines Inc	Composiciones y metodos de construcciones quimericas del virus del dengue en vacunas
EP3010536A4 (de)	2013-06-21	2016-11-30	Merck Sharp & Dohme	Dengue-virus-impfstoffzusammensetzungen und verfahren zur verwendung davon
CN103382509A (zh) *	2013-07-17	2013-11-06	浙江国际旅行卫生保健中心	逆转录-环介导等温扩增检测登革2型病毒的试剂及检测方法
TWI852899B (zh)	2014-09-02	2024-08-21	法商賽諾菲巴斯德公司	疫苗組合物
PH12017501165B1 (en)	2014-12-22	2023-02-22	Merck Sharp & Dohme Llc	Dengue virus vaccine compositions and methods of use thereof
US10857222B2 (en)	2015-07-03	2020-12-08	Sanofi Pasteur	Concomitant dengue and yellow fever vaccination
KR102373570B1 (ko) *	2015-11-27	2022-03-10	케이엠 바이올로직스 가부시키가이샤	뎅기 바이러스 약독주를 뱅크화한 생바이러스, 및 그것들을 항원으로 하는 뎅기 백신
CN105999260B (zh) *	2016-05-13	2019-12-10	四川大学	氢氧化铝凝胶-氯化钠复合免疫佐剂及其制备方法和用途
SG11202002933TA (en)	2017-10-05	2020-04-29	Sanofi Pasteur	Compositions for booster vaccination against dengu
US11464815B2 (en)	2018-09-05	2022-10-11	Takeda Vaccines, Inc.	Dengue vaccine unit dose and administration thereof
CA3111332A1 (en)	2018-09-05	2020-03-12	Takeda Vaccines, Inc.	Dengue vaccine unit dose and administration thereof
US11426461B2 (en)	2018-09-05	2022-08-30	Takeda Vaccines, Inc.	Methods for preventing dengue and hepatitis A

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6093296A (en) *	1995-06-07	1996-12-30	Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The	Infectious dengue 2 virus pdk-53 as quadravalent vaccine
AU779280B2 (en) *	1999-03-26	2005-01-13	Walter Reed Army Institute Of Research	Multivalent dengue virus vaccine
ES2315221T3 (es) *	2000-05-30	2009-04-01	Mahidol University	Cepas atenuadas del virus del dengue y su utilizacion en una composicion vaccinea.
CN1582333B (zh) *	2000-09-25	2010-06-16	波利门科学生物免疫研究有限公司	活疫苗及生产方法
DK2290108T3 (da) *	2001-05-22	2014-10-20	Us Gov Health & Human Serv	Udvikling af mutationer, der er anvendelige til svækkelse af dengue-vira, samt kimære dengue-vira
ES2677348T3 (es) *	2002-05-03	2018-08-01	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Un virus del dengue quimérico recombinante rDEN3/4delta 30(ME), rDEN2/4delta30(ME) o rDEN1/4delta30(ME) que contiene una deleción de 30 nucleótidos (delta30) en una sección de la región no traducida en 3' del genoma del dengue de tipo 4, en donde dicha deleción de 30 nucleótidos se corresponde con la estructura tallo-bucle de TL2
JP5075120B2 (ja) *	2005-06-17	2012-11-14	サノフィ・パスツール	デング熱セロタイプ２の弱毒化株

2006
- 2006-06-07 JP JP2008516431A patent/JP5075120B2/ja not_active Expired - Fee Related
- 2006-06-07 DE DE602006015807T patent/DE602006015807D1/de active Active
- 2006-06-07 EP EP06755943A patent/EP1891210B1/de active Active
- 2006-06-07 MX MX2007015872A patent/MX2007015872A/es active IP Right Grant
- 2006-06-07 BR BRPI0613287-1A patent/BRPI0613287A2/pt not_active IP Right Cessation
- 2006-06-07 AU AU2006257621A patent/AU2006257621B2/en not_active Ceased
- 2006-06-07 CN CN2006800285156A patent/CN101238209B/zh not_active Expired - Fee Related
- 2006-06-07 KR KR1020087001413A patent/KR20080018271A/ko active IP Right Grant
- 2006-06-07 KR KR1020147001614A patent/KR101582163B1/ko not_active Expired - Fee Related
- 2006-06-07 AT AT06755943T patent/ATE475706T1/de not_active IP Right Cessation
- 2006-06-07 WO PCT/IB2006/001513 patent/WO2006134443A1/en active Application Filing
- 2006-06-07 CA CA2611954A patent/CA2611954C/en not_active Expired - Fee Related
- 2006-06-14 MY MYPI20062801A patent/MY144542A/en unknown
- 2006-06-14 MY MYPI2011006054A patent/MY161457A/en unknown
- 2006-06-15 US US11/453,344 patent/US7641908B2/en active Active
- 2006-06-16 AR ARP060102567A patent/AR053914A1/es unknown
- 2006-06-16 TW TW095121611A patent/TWI375722B/zh not_active IP Right Cessation
2007
- 2007-12-11 ZA ZA200710752A patent/ZA200710752B/xx unknown
- 2007-12-12 NO NO20076360A patent/NO20076360L/no not_active Application Discontinuation
- 2007-12-12 IL IL188068A patent/IL188068A0/en not_active IP Right Cessation
2009
- 2009-12-08 US US12/633,459 patent/US8067566B2/en active Active
2011
- 2011-10-25 US US13/281,255 patent/US8795688B2/en active Active
2014
- 2014-08-04 US US14/450,529 patent/US20150031857A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ZA200710752B (en)	2008-12-31
JP2008546383A (ja)	2008-12-25
US20070026016A1 (en)	2007-02-01
US20120083585A1 (en)	2012-04-05
TW200738881A (en)	2007-10-16
CA2611954A1 (en)	2006-12-21
EP1891210A1 (de)	2008-02-27
IL188068A0 (en)	2008-03-20
ATE475706T1 (de)	2010-08-15
MX2007015872A (es)	2008-04-21
CN101238209A (zh)	2008-08-06
KR20140019034A (ko)	2014-02-13
KR20080018271A (ko)	2008-02-27
MY144542A (en)	2011-09-30
US20150031857A1 (en)	2015-01-29
CA2611954C (en)	2014-01-28
AU2006257621A1 (en)	2006-12-21
JP5075120B2 (ja)	2012-11-14
US8795688B2 (en)	2014-08-05
BRPI0613287A2 (pt)	2010-12-28
US8067566B2 (en)	2011-11-29
AU2006257621B2 (en)	2011-08-11
AR053914A1 (es)	2007-05-23
DE602006015807D1 (de)	2010-09-09
KR101582163B1 (ko)	2016-01-05
CN101238209B (zh)	2013-02-13
US7641908B2 (en)	2010-01-05
MY161457A (en)	2017-04-14
WO2006134443A1 (en)	2006-12-21
EP1891210B1 (de)	2010-07-28
TWI375722B (en)	2012-11-01
US20100174057A1 (en)	2010-07-08

Publication	Publication Date	Title
NO20076360L (no)	2008-03-11	Dengue serotype 2 attenuert stamme
NO20076355L (no)	2008-03-11	Dengue serotype 1 attenuert stamme
NO2019004I1 (no)	2019-01-29	patisiran: dekket gjennom sekvensene i kravene 1, 8 og 9 (se særlig krav 8 (b) og (c) i patentet. Det vises også til følgebrevet til søknaden.
HUS1700024I1 (hu)	2017-06-28	Rekombináns, alfa-2,3- és alfa-2,6-szializációt tartalmazó FSH
SG159542A1 (en)	2010-03-30	Compositions against sars-coronavirus and uses thereof
MX2012004310A (es)	2012-05-08	Metodo para caracterizar almenos un microorganismo por medio de espectrometria de masa.
MA30153B1 (fr)	2009-01-02	Anticorps anti-ox40l et methodes correspondantes
DK1965809T3 (da)	2010-01-04	Præparater til forbedring af sundhedstilstanden i dyrs tarmsystem og dyrs ydeevne omfattende Beta-glucanerne og Alfa-fucaner
WO2007055714A3 (en)	2009-04-16	Compositions and methods for the evaluation and resuscitation of cadaveric hearts for transplant
MX2007008723A (es)	2007-09-12	Polipeptidos de yersinia spp y metodos de uso.
NO20074885L (no)	2007-11-22	N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus
EP2499134A4 (de)	2013-04-17	Sauerstofffänger, zusammensetzung mit den fängern sowie aus der zusammensetzung hergestellte artikel
WO2007034395A3 (en)	2008-10-30	Luminescence sensor comprising at least two wire grids
NO20082704L (no)	2008-08-11	Hepatitt C virusvarianter
CL2008000518A1 (es)	2008-04-18	Composicion de control de plagas que comprende etofenprox y un compuesto desinfectante seleccionado entre flusulfamida, himexazol, simeconazol, y pentiopirad; y metodo de prevencion del dano producido por plagas.
WO2007002587A3 (en)	2007-05-24	Inhibitors of epstein barr virus nuclear antigen 1
IL187915A0 (en)	2008-03-20	1,2-di(cyclic group)substituted benzene derivative
BRPI0615384B8 (pt)	2021-05-25	composições oftálmicas de cetotifeno estabilizadas e conservadas
EA200801297A1 (ru)	2008-10-30	Способ снижения уровня постпрандиальной глюкозы
NO20091386L (no)	2009-05-06	Fenyloksyanilinderivater
NO20074136L (no)	2007-09-10	Orale sammensetninger for forebygging av UV-skader
DK1915441T3 (da)	2013-10-21	Fremgangsmåde til at fjerne bisulfit-biprodukter fra enzymsammensætninger
FR2922211B1 (fr)	2009-12-04	Peptides cycliques comprenant au moins un residu azabeta3 aminoacycle et leurs utilisations
WO2008058706A3 (de)	2008-11-20	Enterococcus faecalis- und/oder enterococcus faecium-antigen
TR200805195T1 (tr)	2008-10-21	Antep fıstığı dal güvesi, kermania pistaciella'nın (lepidoptera: oinophilidae) davranışını etkilemeye dönük kimyasallara ait bileşim.

Legal Events

Date	Code	Title	Description
2018-01-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application